India needs financial risk coverage for commercial space launch industry
Related Articles
-
‘We need to take risks’: Chanel gets gritty with Marseille show
Luxury brand continues its strategy of engaging with diversity and real life – but the prices are less inclusiveGrey hoodies layered under the pastel tweed suits, a catwalk on top of an apartment building with concrete benches instead of gilt chairs, looking out over the rooftops of Marseille, France’s less manicured second city. Chanel has – in fashion speak – a New Look. In the parlance of 2024, it is in its gritty era.“If Marseille is unexpected, that’s good. We don’t want to be stuck. We...
-
Covishield, Marketed In India By Serum Institute Reported To Raise Disorder Risk
NEW DELHI, (IANS) – Thrombosis Thrombocytopenia Syndrome (TTS) — a blood clot disorder — is a rare side effect of AstraZeneca’s Covid vaccine, and the benefits far outweigh the risks of the jab, said doctors here on April 30. This comes after reports said that […]
-
AstraZeneca's admission of Covishield risk may spark legal battles in India
Pharmaceutical giant AstraZeneca has legally acknowledged for the first time that its COVID-19 vaccine, under the global brand names Covishield and Vaxzevria, could trigger a rare adverse health condition.The vaccine producer stated in court documents that the inoculation could occasionally induce Thrombosis with Thrombocytopenia Syndrome (TTS), a disorder resulting in blood clots and a reduced platelet count, as reported in The Telegraph. A class action lawsuit, on account of allegations that...